GJ Moyle

906 total citations
13 papers, 529 citations indexed

About

GJ Moyle is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, GJ Moyle has authored 13 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Virology and 5 papers in Epidemiology. Recurrent topics in GJ Moyle's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). GJ Moyle is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). GJ Moyle collaborates with scholars based in United Kingdom. GJ Moyle's co-authors include D.J. Back, Sharon Brown, Sundhiya Mandalia, N. Sibtain, Caitlin Priest, BG Gazzard, Keith McCormick, Mark Bower, Rachael Jones and Mark Nelson and has published in prestigious journals such as International Journal of Clinical Practice, HIV Medicine and PubMed.

In The Last Decade

GJ Moyle

13 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
GJ Moyle United Kingdom	6	274	205	178	149	102	13	529
Barbara Beghetto Italy	10	180 0.7×	104 0.5×	28 0.2×	264 1.8×	84 0.8×	17	354
F Mulcahy Ireland	10	108 0.4×	38 0.2×	9 0.1×	57 0.4×	94 0.9×	24	303
K. Kombaté Togo	10	86 0.3×	14 0.1×	97 0.5×	20 0.1×	92 0.9×	71	342
José Antonio Alonso‐Cadenas Spain	10	261 1.0×	16 0.1×	207 1.2×	10 0.1×	90 0.9×	27	411
I-An Jen Taiwan	13	107 0.4×	73 0.4×	20 0.1×	38 0.3×	104 1.0×	22	353
Nerea Egüés Spain	9	80 0.3×	9 0.0×	19 0.1×	35 0.2×	51 0.5×	14	258
Khadija Boussetta Tunisia	10	76 0.3×	16 0.1×	17 0.1×	26 0.2×	65 0.6×	41	345
Cecile D. Lahiri United States	12	280 1.0×	135 0.7×	3 0.0×	299 2.0×	88 0.9×	45	474
Maria Gussio Italy	10	112 0.4×	39 0.2×	2 0.0×	35 0.2×	99 1.0×	24	245
Alina Burgi United States	6	131 0.5×	27 0.1×	22 0.1×	21 0.1×	93 0.9×	7	395

Countries citing papers authored by GJ Moyle

Since Specialization

Citations

This map shows the geographic impact of GJ Moyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GJ Moyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GJ Moyle more than expected).

Fields of papers citing papers by GJ Moyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GJ Moyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GJ Moyle. The network helps show where GJ Moyle may publish in the future.

Co-authorship network of co-authors of GJ Moyle

This figure shows the co-authorship network connecting the top 25 collaborators of GJ Moyle. A scholar is included among the top collaborators of GJ Moyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GJ Moyle. GJ Moyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Moyle, GJ, et al.. (2006). Long‐term safety and efficacy of poly‐L‐lactic acid in the treatment of HIV‐related facial lipoatrophy. HIV Medicine. 7(3). 181–185. 80 indexed citations

McCormick, Keith, et al.. (2005). Better maintained adherence on switching from twice‐daily to once‐daily therapy for HIV: a 24‐week randomized trial of treatment simplification using stavudine prolonged‐release capsules. HIV Medicine. 6(3). 185–190. 56 indexed citations

Jones, Rachael, Shailendra Sawleshwarkar, Christos Michailidis, et al.. (2005). Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. HIV Medicine. 6(6). 396–402. 55 indexed citations

Moyle, GJ, et al.. (2004). A randomized open‐label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Medicine. 5(2). 82–87. 171 indexed citations

Moyle, GJ & D.J. Back. (2001). Principles and practice of HIV‐protease inhibitor pharmacoenhancement. HIV Medicine. 2(2). 105–113. 142 indexed citations

Moyle, GJ, et al.. (1997). The role of stavudine in the management of adults with HIV infection.. PubMed. 2(4). 207–18. 5 indexed citations

Moyle, GJ, et al.. (1997). The role of didanosine in the management of HIV-1 infection.. PubMed. 2(3). 135–47. 5 indexed citations

Moyle, GJ, et al.. (1996). Safety and activity of zalcitabine and zidovudine combination in HIV-positive people with CD4 cell counts < or = 300 cells/mm3. The Roche M50002 Study Group.. PubMed. 1(3). 180–8. 4 indexed citations

Moyle, GJ, et al.. (1995). Individualisation of HIV therapy: the clinician's perspective.. PubMed. 49(3). 145–7. 3 indexed citations

10.

Gazzard, BG & GJ Moyle. (1995). INDIVIDUALISATION OF HIV THERAPY: THE CLINICIAN'S PERSPECTIVE. International Journal of Clinical Practice. 49(3). 145–147. 2 indexed citations

11.

Moyle, GJ, et al.. (1995). AIDS: clinical and scientific issues past, present and future.. PubMed. 39(3). 156–62. 1 indexed citations

12.

Moyle, GJ, et al.. (1978). Chronic illness in non-institutionalized persons. Part II. Who cares?. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 53(23). 928–37. 2 indexed citations

13.

Dick, Bruce, et al.. (1978). Chronic illness in non-institutionalized persons. Part I. Prevalence and epidemiology.. PubMed. 53(22). 892–904. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact